Skip to Main Content

Paper Details

Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Mol Cancer
67
2014
ENO1, ETP, ETPs, Epidithiodiketopiperazines, HIF, HIF-1, HIF-1 target gene, HIF-1 target genes, LDHA, VEGF, VEGFA, antitumor, cancer, chaetocin, chetomin, epidithiodiketopiperazine, gliotoxin, hypoxia inducible factor-1 alpha, mRNA, mice, p300, prostate, prostate cancer, prostate tumor, rat, treated cells, tumor

Datasets

Release 1.2